Mogamulizumab-kpkc Intravenous and Rabeprazole Delayed Release Capsules
Determining the interaction of Mogamulizumab-kpkc Intravenous and Rabeprazole Delayed Release Capsules and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: mogamulizumab
Brand name: Poteligeo
Synonyms: Mogamulizumab
Generic Name: rabeprazole
Brand name: Aciphex, AcipHex Sprinkle
Synonyms: Rabeprazole, RABEprazole
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Mogamulizumab-kpkc Intravenous-Rabeprazole Delayed-Release Tablets
- Mogamulizumab-kpkc Intravenous-Rabeprazole Sodium
- Mogamulizumab-kpkc Intravenous-Rabeprazole Sprinkle Capsules
- Mogamulizumab-kpkc Intravenous-Rabies Immune Globulin
- Mogamulizumab-kpkc Intravenous-Rabies immune globulin human
- Mogamulizumab-kpkc Intravenous-Rabies immune globulin Intramuscular
- Rabeprazole Delayed Release Capsules-Molindone
- Rabeprazole Delayed Release Capsules-Mometasone (Oral Inhalation)
- Rabeprazole Delayed Release Capsules-Mometasone and Formoterol
- Rabeprazole Delayed Release Capsules-Mometasone and formoterol Inhalation
- Rabeprazole Delayed Release Capsules-Mometasone Cream
- Rabeprazole Delayed Release Capsules-Mometasone Furoate